STOCK TITAN

Hercules Capital Inc - HTGC STOCK NEWS

Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.

Hercules Capital, Inc. (NYSE: HTGC) is a premier specialty finance company dedicated to providing senior secured loans to high-growth, venture capital-backed companies in technology-related markets. Established in December 2003, Hercules has positioned itself as a key player in the venture lending space, committing over $4.6 billion to more than 300 companies across various stages of development. The company focuses on sectors such as technology, biotechnology, life sciences, and sustainable and renewable energy.

Hercules Capital stands out by offering more than just financial support. The company provides vital access to its expansive network of contacts and invaluable business advice, helping entrepreneurial companies achieve significant milestones. Their investment portfolio includes a mix of structured debt with warrants, senior debt, and equity investments.

Recent achievements include a $35 million loan facility to SynOx Therapeutics Limited to support the development of emactuzumab, a next-generation monoclonal antibody for treating Tenosynovial Giant Cell Tumour (TGCT). Another notable investment is the $150 million financing to Harness, a Modern Software Delivery Platform company, to expand its platform with new modules and enhance its use of generative AI.

Hercules Capital’s strategic partnerships and financial solutions make it the lender of choice for venture-backed companies seeking reliable growth capital. The company’s financial stability and extensive industry expertise ensure that it remains a trusted partner for innovation-driven businesses looking to scale.

Rhea-AI Summary

Provention Bio, Inc. (Nasdaq: PRVB) has announced the closing of a $40 million second tranche under a $125 million term loan facility with Hercules Capital (NYSE: HTGC). This funding aims to support the commercial launch of TZIELD®, a treatment for Stage 2 type 1 diabetes. CEO Ashleigh Palmer highlighted the positive reception of TZIELD® from patients and prescribers, noting favorable coverage policies from major payers. The loan facility will be drawn in multiple tranches, with further funding contingent upon milestone achievements. The revised loan terms will lower the interest rate, enhancing financial flexibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.07%
Tags
none
-
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) has announced its conference call for fourth quarter and full-year 2022 financial results, scheduled for February 16, 2023, at 2:00 p.m. PT. The company, a leader in providing specialty financing to innovative growth companies, will release its financial results after market close that day. Hercules has committed over $16 billion to more than 600 companies since its inception in December 2003, focusing primarily on technology and life sciences sectors. Investors can access the call via registration, with a live webcast also available on its investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) announced its participation in the KBW BDC Midtown event on December 14, 2022, in New York, NY. The company, a leading specialty finance provider, focuses on senior secured venture growth loans for high-growth, venture capital-backed firms across technology, life sciences, and renewable sectors. Since December 2003, Hercules has committed over $16 billion to more than 600 companies, positioning itself as a crucial lender for entrepreneurs. Additionally, Hercules has a retail bond issuance (NYSE: HCXY).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
none
Rhea-AI Summary

On November 16, 2022, Silicon Valley Bank and Hercules Capital announced a $300 million credit facility for Oak Street Health (NYSE: OSH). This financing aims to support Oak Street's operational and strategic initiatives over several years. The partnership reflects strong relationships built over the years. Oak Street Health focuses on value-based primary care for Medicare-eligible patients, particularly those in underserved communities. The collaboration underlines both banks' commitment to healthcare innovation and Oak Street's growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
none
-
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) has announced the participation of its executive management team in several upcoming financial community events. These include the Jefferies BDC Summit and FitchRatings BDC Conference on November 16, 2022, followed by the JMP Securities Financial Services and Real Estate Conference on November 17, 2022. Hercules Capital, the largest specialty financing provider, has committed over $16 billion to more than 600 companies since its inception in December 2003, focusing on senior secured venture growth loans for innovative sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
none
-
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) reported a record total gross debt and equity commitments of $2.48 Billion for Q3 2022, with gross fundings reaching $1.10 Billion. The company saw a net debt portfolio growth of $465.1 Million and total investment income increased by 20% year-over-year to $84.2 million. Hercules also announced a net investment income of $0.39 per share, covering the increased base distribution payout of $0.36.

Undistributed earnings stand at $134.1 Million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
Rhea-AI Summary

Bright Machines has secured $132M in its latest funding round, comprised of $100M in equity led by Eclipse Ventures and $32M in debt from Silicon Valley Bank (NASDAQ: SIVB) and Hercules Capital (NYSE: HTGC). This funding aims to enhance the company's software-defined manufacturing capabilities, expand into new industry verticals, and develop additional service offerings. With this round, Bright Machines' total funding since 2018 reaches $330M, positioning it for continued growth in the $250B industrial automation market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
-
Rhea-AI Summary

Tricida, Inc. (NASDAQ: TCDA) announced a $125 million debt facility with Hercules Capital, Inc. (NYSE: HTGC). Of this, $100 million is available for Tricida upon meeting certain milestones. This financing aims to support the upcoming NDA resubmission and FDA approval for their drug, veverimer, designed to treat chronic kidney disease (CKD). The loan allows for interest-only payments until August 2024, with possible extensions based on FDA decisions. This partnership is intended to provide non-dilutive capital for Tricida's ongoing development of veverimer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
none
-
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) has scheduled its third quarter 2022 financial results conference call for November 2, 2022, at 2:00 p.m. PT (5:00 p.m. ET). Financial results will be released after market close on the same day. The company is a leader in providing senior secured venture growth loans, having committed over $15 billion to more than 590 companies since its inception in December 2003. Investors can access a live webcast of the call on their website, with an archived version available for 30 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.34%
Tags
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) has announced a supplemental cash distribution of $0.15 per share, set to be paid on November 17, 2022, following the record date of November 10, 2022. This distribution is in addition to the regular quarterly cash distribution of $0.36 per share for Q3 2022. The supplemental distribution is derived from undistributed taxable income as of September 30, 2022. Hercules' Board aims to distribute approximately 90% to 100% of its taxable income annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.87%
Tags
none

FAQ

What is the current stock price of Hercules Capital (HTGC)?

The current stock price of Hercules Capital (HTGC) is $21.47 as of February 21, 2025.

What is the market cap of Hercules Capital (HTGC)?

The market cap of Hercules Capital (HTGC) is approximately 3.8B.

What does Hercules Capital, Inc. specialize in?

Hercules Capital specializes in providing senior secured loans to venture capital-backed companies in technology-related industries.

Which industries does Hercules Capital, Inc. focus on?

Hercules Capital focuses on technology, biotechnology, life sciences, and sustainable and renewable energy sectors.

How much has Hercules Capital, Inc. committed since its inception?

Since its inception in December 2003, Hercules Capital has committed over $4.6 billion to more than 300 companies.

What kind of financial products does Hercules Capital, Inc. offer?

Hercules Capital offers a mix of structured debt with warrants, senior debt, and equity investments.

Can you provide an example of a recent investment by Hercules Capital, Inc.?

A recent investment by Hercules Capital includes a $35 million loan facility to SynOx Therapeutics Limited for developing emactuzumab.

Why do companies choose Hercules Capital, Inc.?

Companies choose Hercules Capital for its reliable growth capital, access to an extensive network of contacts, and valuable business advice.

How does Hercules Capital, Inc. support its portfolio companies beyond financial investment?

Beyond financial investment, Hercules Capital offers access to a wide network of contacts and essential business advice to help companies achieve key milestones.

What is a notable recent achievement of Hercules Capital, Inc.?

A notable recent achievement is the $150 million financing to Harness to support the expansion of their software delivery platform.

How does Hercules Capital, Inc. ensure its financial stability?

Hercules ensures financial stability through strategic partnerships, diversified investment portfolios, and deep industry expertise.

What is the significance of Hercules Capital, Inc. in the venture lending space?

Hercules Capital is a leading lender of choice for entrepreneurs and venture capital firms, highlighted by its extensive commitments and successful partnerships with high-growth companies.
Hercules Capital Inc

Nasdaq:HTGC

HTGC Rankings

HTGC Stock Data

3.76B
169.33M
1.76%
25.96%
3%
Asset Management
Financial Services
Link
United States
SAN MATEO